New European Study Finds Active Childhood Myopia Control Can Reduce Lifetime Costs and Vision Burden

A newly published European study suggests that early, active management of myopia in children could significantly reduce the lifetime financial and health burden associated with the condition compared with traditional corrective approaches. The findings, published in the American Journal of Ophthalmology, have important implications for vision care strategies across Europe as rates of myopia continue to rise.

The study assessed projected lifetime costs of myopia using economic models that compared traditional myopia management—such as single-vision spectacles or contact lenses—with active myopia control strategies, including low-dose atropine, special anti-myopia spectacles, multifocal contact lenses, and orthokeratology.

Researchers found that while active myopia control requires higher upfront investment during childhood, these interventions may reduce the total lifetime cost of vision care. This is achieved through slower progression of myopia, which in turn can lead to simpler corrective lens needs, fewer complex prescriptions, and a lower risk of serious eye pathology later in life.

“Investing in active myopia treatments during childhood appears to lower the long-term economic burden of vision care compared with traditional correction alone,” the authors stated. “Children predicted to experience faster progression show the greatest potential benefit from early intervention.”

The study underscores a growing body of evidence that proactive myopia control not only benefits individual eye health but can also offer economic advantages by reducing costs associated with advanced myopia and its complications over a person’s lifetime.

The researchers say the findings provide policymakers and clinicians with data to support early myopia management programs and could inform future public health initiatives aimed at mitigating the long-term impact of the condition.

Originally published online on Eyewire+.